Summary of the World Health Organization’s guidelines for management for patients with coronavirus infection

Abstract

A brief overview of the guidelines for the management of patients with the new coronavirus infection COVID-19 published by the World Health Organization guidelines in May 2020 is presented. The article covers sections that primarily concern the medical care to patients with COVID-19 in outpatient settings.

Keywords

COVID-19 / coronavirus infection / diagnosis / treatment / general practice

References

[1] World Health Organization. Clinical management of COVID-19: interim guidance. 2020 [cited 27 May 2020]. Available from: https://www.who.int/publications/i/item/clinical-management-of-covid-19.

[2] Burke RM, Midgley CM, Dratch A, et al. Active monitoring of persons exposed to patients with confirmed COVID19 — United States, January-February 2020. MMWR Morb Mortal Wkly Rep. 2020;69(9):245-246. https://doi.org/10.15585/mmwr.mm6909e1.

[3] Ong SW, Tan YK, Chia PY, et al. Air, surface environmental, and personal protective equipment contamination by severe acute respiratory Syndrome Coronavirus 2 (SARS-CoV-2) from a symptomatic patient. JAMA. 2020;323(16):1610-1612. https://doi.org/10.1001/jama.2020.3227.

[4] Lauer SA, Grantz KH, Bi Q, et al. The incubation period of Coronavirus Disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application. Ann Intern Med. 2020;172(9):577-558. https://doi.org/10.7326/M20-0504.

[5] Liu Y, Yan LM, Wan L, et al. Viral dynamics in mild and severe cases of COVID-19. Lancet Infect Dis. 2020;20(6):656-6576. https://doi.org/10.1016/S1473-3099(20)30232-2.

[6] Yu P, Zhu J, Zhang Z, et al. A familial cluster of infection associated with the 2019 novel coronavirus indicating potential person-to-person transmission during the incubation period. J Infect Dis. 2020;221(11):1757-1761. https://doi.org/10.1093/infdis/jiaa077.

[7] Huang R, Xia J, Chen Y, et al. A family cluster of SARS-CoV-2 infection involving 11 patients in Nanjing, China. Lancet Infect Dis. 2020;20(5):534-535. https://doi.org/10.1016/S1473-3099(20)30147-X.

[8] Pan X, Chen D, Xia Y, et al. Asymptomatic cases in a family cluster with SARS-CoV-2 infection. Lancet Infect Dis. 2020;20(4):410-411. https://doi.org/10.1016/S1473-3099(20)30114-6.

[9] Tong ZD, Tang A, Li KF, et al. Potential presymptomatic transmission of SARS-CoV-2, zhejiang province, China, 2020. Emerg Infect Dis. 2020;26(5):1052-1054. https://doi.org/10.3201/eid2605.200198.

[10] Wei WE, Li Z, Chiew CJ, et al. Presymptomatic transmission of SARS-CoV-2 — Singapore, January 23 — March 16, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(14):411-415. https://doi.org/10.15585/mmwr. mm6914e1.

[11] Novel coronavirus pneumonia emergency response epidemiology team. Vital surveillances: the epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) — China. China CDC Weekly. 2020;2(8):113-122. https://doi.org/10.3760/cma.j.issn.0254-6450.2020.02.003.

[12] Arons MM, Hatfield KM, Reddy SC, et al. Presymptomatic SARS-CoV-2 infections and transmission in a skilled nursing facility. N Engl J Med. 2020;382(22):2081-2090. https://doi.org/10.1056/NEJMoa2008457.

[13] McMichael TM, Currie DW, Clark S, et al. Epidemiology of COVID-19 in a long-term care facility in King County, Washington. N Engl J Med. 2020;382(21):2005-2011. https://doi.org/10.1056/NEJMoa2005412.

[14] Tay HS, Harwood R. Atypical presentation of COVID-19 in a frail older person. Age Ageing. 2020;49(4):523-524. https://doi.org/10.1093/ageing/afaa068.

[15] Dengue guidelines for diagnosis, treatment, prevention and control. Geneva: World Health Organization; 2009. 147 р. Available from: https://www.who.int/neglected_diseases/resources/9789241547871/en/.

[16] WHO. WHO guidelines on tuberculosis infection prevention and control. Geneva: World Health Organization; 2019. Available from: https://www.who.int/tb/publications/2019/guidelines-tuberculosis-infection-prevention-2019/en/.

[17] Information Note. Tuberculosis and COVID-19. Geneva: World Health Organization; 2020 [cited 12 May 2020]. Available from: https://www.who.int/tb/COVID_19considerations_tuberculosis_services.pdf.

[18] Guidelines for the treatment of malaria, 3rd edition. Geneva: World Health Organization; 2015. 317 р. Available from: http://apps.who.int/iris/bitstream/10665/162441/1/9789241549127_eng.pdf?ua=1&ua=1.

[19] Guidelines for treatment of drug-susceptible tuberculosis and patient care. Geneva: World Health Organization; 2017. Available from: https://www.who.int/tb/publications/2017/dstb_guidance_2017/en/.

[20] Infection prevention and control guidance for long-term care facilities in the context of COVID-19. Geneva: World Health Organization; 2020 [cited 13 May 2020]. Available from: https://www.who.int/publications-detail/infection-prevention-and-control-for-long-term-care-facilities-in-the-context-of-covid-19.

[21] WHO-ICRC Basic Emergency Care: approach to the acutely ill and injured. Geneva: World Health Organization; 2018 [cited 30 October 2018]. Available from: https://www.who.int/publications-detail/basic-emergency-care-approach-to-the-acutely-ill-and-injured.

[22] Clinical care for severe acute respiratory infections Tool kit: COVID-19 adaptation. Geneva: World Health Organization; 2020 [cited 11 April 2020]. Available from: https://www.who.int/publications-detail/clinical-care-of-severe-acute-respiratory-infections-tool-kit.

[23] Wu Z, McGoogan JM. Characteristics of and important lessons from the Coronavirus Disease 2019 (COVID-19) Outbreak in China: summary of a report of 72314 cases from the chinese center for disease control and prevention. JAMA. 2020. https://doi.org/10.1001/jama.2020.2648.

[24] Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8(5):475-481. https://doi.org/10.1016/S2213-2600(20)30079-5.

[25] Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. https://doi.org/10.1016/S0140-6736(20)30183-5.

[26] Spinato G, Fabbris C, Polesel J, et al. Alterations in smell or taste in mildly symptomatic outpatients with SARSCoV-2 infection. JAMA. 2020;323(20):2089-2090. https://doi.org/10.1001/jama.2020.6771.

[27] Giacomelli A, Pezzati L, Conti F, et al. Self-reported olfactory and taste disorders in SARS-CoV-2 patients: a crosssectional study. Clin Infect Dis. 2020;ciaa330. https://doi.org/10.1093/cid/ciaa330.

[28] Tong JY, Wong A, Zhu D, et al. The prevalence of olfactory and gustatory dysfunction in COVID-19 patients: a systematic review and meta-analysis. Otolaryngol Head Neck Surg. 2020;163(1):3-11. https://doi.org/10.1177/0194599820926473.

[29] Elshafeey F, Magdi R, Hindi N, et al. A systematic scoping review of COVID-19 during pregnancy and childbirth. Int J Gynaecol Obstet. 2020;150(1):47-52. https://doi.org/10.1002/ijgo.13182.

[30] CDC COVID-19 Response Team. Coronavirus Disease 2019 in Children — United States, February 12 — April 2, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(14):422-426. https://doi.org/10.15585/mmwr.mm6914e4.

[31] Laboratory testing strategy recommendations for COVID-19. Geneva: World Health Organization; 2020 [cited 21 March 2020]. Available from: https://apps.who.int/iris/bitstream/handle/10665/331509/WHO-COVID-19-lab_testing-2020.1-eng.pdf.

[32] Rawson TM, Moore LS, Zhu N, et al. Bacterial and fungal co-infection in individuals with coronavirus: A rapid review to support COVID-19 antimicrobial prescribing. Clin Infect Dis. 2020;ciaa530. https://doi.org/10.1093/cid/ciaa530.

[33] Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507-513. https://doi.org/10.1016/S0140-6736(20)30211-7.

[34] Goossens H, Ferech M, Vander Stichele R, Elseviers M; ESAC Project Group. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet. 2005;365(9459):579-587. https://doi.org/10.1016/S0140-6736(05)17907-0.

[35] Llor C, Bjerrum L. Antimicrobial resistance: risk associated with antibiotic overuse and initiatives to reduce the problem. Ther Adv Drug Saf. 2014;5(6):229-241. https://doi.org/10.1177/2042098614554919.

[36] Struelens MJ. The epidemiology of antimicrobial resistance in hospital acquired infections: problems and possible solutions. BMJ. 1998;317(7159):652-654. https://doi.org/10.1136/bmj.317.7159.652.

[37] Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054-1062. https://doi.org/10.1016/S0140-6736(20)30566-3.

RIGHTS & PERMISSIONS

Moiseeva I.E.